Biomarkers for Cardiometabolic Risk: Pathophysiology, Impact, Advances and Challenges
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: 31 May 2024 | Viewed by 227
Special Issue Editors
Interests: medicine; biochemistry; genetics and molecular biology cardiovascular disease
Special Issues, Collections and Topics in MDPI journals
Interests: metabolic disease; organ pathophysiology; cardiovascular disease; metabolomic ad lipidomic technology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Cardiometabolic (CM) diseases remain the leading cause of morbidity and mortality worldwide, suggesting the importance of new, reliable tools to evaluate their occurrence. In reality, a number of different biomarkers continue to be proposed and tested, giving further insights into the pathophysiological mechanisms underlying cardiometabolic conditions. However, generally, they give only a moderate increase in the predictive value over the use of tools based on classic and consolidated risk factors included in traditional risk scores. The simultaneous measurement of multiple biomarker parameters (the multimarker approach) seems to add a substantial advantage, which can provide an accurate prediction for specific patients and drive targeted preventive therapy.
We invite investigators to contribute either original research or review articles to this Special Issue; the topics of interest include, but are not limited to:
- The role of different biomarkers, including established CM biomarkers, as well as emerging biomarkers identified through omics technologies (e.g., the combination of genomics, transcriptomics, epigenetics, and proteomics) used alone or in multiple biomarker combinations to improve our CM pathophysiological knowledge.
- In addition to the pathophysiological significance, we are interested in the technical aspects still challenging the analysis of molecular biomarkers, as well as translational issues.
Dr. Cristina Vassalle
Dr. Melania Gaggini
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- biomarker
- cardiovascular risk
- cardiometabolic disease
- omics technologies
- genomics
- transcriptomics
- epigenetics
- proteomics
- translational medicine
